These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17221824)

  • 1. [The dystonias--botulinum toxin, deep brain stimulation, pharmacotherapy, motor training].
    Ceballos-Baumann A
    Ther Umsch; 2007 Jan; 64(1):41-53. PubMed ID: 17221824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical aspects of the medical treatment in dystonia].
    Grabli D; Vidailhet M
    Bull Acad Natl Med; 2011; 195(4-5):935-50. PubMed ID: 22375361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dystonia.
    Jankovic J
    Lancet Neurol; 2006 Oct; 5(10):864-72. PubMed ID: 16987733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic challenges in dystonia.
    Kartha N
    Neurol Clin; 2010 Nov; 28(4):927-40. PubMed ID: 20816271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches in the treatment of the dystonias.
    Diederich N; Goetz CG; Comella CL
    Klin Wochenschr; 1990 Oct; 68(19):935-41. PubMed ID: 2232624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystonia.
    Balint B; Mencacci NE; Valente EM; Pisani A; Rothwell J; Jankovic J; Vidailhet M; Bhatia KP
    Nat Rev Dis Primers; 2018 Sep; 4(1):25. PubMed ID: 30237473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in dystonia.
    Albanese A; Romito LM; Calandrella D
    Mov Disord; 2015 Sep; 30(11):1547-56. PubMed ID: 26301801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurses' role in management and treatment of dystonia.
    Grant SA; Meager P
    Nurs Times; 2005 May 10-16; 101(19):50-1. PubMed ID: 15920872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFNS guidelines on diagnosis and treatment of primary dystonias.
    Albanese A; Asmus F; Bhatia KP; Elia AE; Elibol B; Filippini G; Gasser T; Krauss JK; Nardocci N; Newton A; Valls-Solé J
    Eur J Neurol; 2011 Jan; 18(1):5-18. PubMed ID: 20482602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dystonias.
    Markham CH
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):301-7. PubMed ID: 1623256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dystonia].
    Schmidt A; Schneider SA; Hagenah J; Klein C
    Nervenarzt; 2008 Sep; 79 Suppl 2():53-63; quiz 64-5. PubMed ID: 18685824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IncobotulinumtoxinA and Deep Brain Stimulation.
    Soh D; Fasano A
    Can J Neurol Sci; 2019 Sep; 46(5):603-606. PubMed ID: 31196241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.